Toshiba receives FDA approval for new MR software upgrade

To streamline diagnosis and enable greater overall exam efficiency, Toshiba America Medical Systems, Inc. has announced FDA approval of VirtualExplorer Version 3.1, a software upgrade package for Toshiba MR VirtualExplorer workstations. The software provides enhanced post-processing functionality, and the new cardiac package includes MR Flow Analysis, which allows clinicians to measure flow and velocity when imaging the heart.

"Toshiba's new MR software upgrade is an example of our commitment to developing the most advanced technology that allows optimal efficiency for our customers," said Stuart Clarkson, director, MR Business Unit, Toshiba. "With advanced features like MR Flow Analysis, clinicians have the ability to streamline cardiac diagnosis for enhanced patient care."

VirtualExplorer Version 3.1 includes features such as 3D image visualization, DICOM Viewer, 2D filming, Double Oblique and Virtual Endoscope. The Cardiac Edition of the software upgrade also includes features specific to cardiac imaging, such as MR Flow Analysis, MR Cardiac Analysis, MR Coronary Analysis and Delayed Enhancement. Additionally, the Neuro Edition of the software includes Brain Perfusion for neuro evaluation.